Table 4.
Entities with the highest production of patents during 2004–2011.
| Entities | Patents |
|---|---|
| Univ California [US] | 315 |
| Genentech Inc [US] | 302 |
| Novartis AG [CH] | 268 |
| Abbott Lab [US] | 155 |
| Wyeth Corp [US] | 152 |
| Glaxo Group Ltd [GB] | 148 |
| US Government [US] | 146 |
| Univ Johns Hopkins [US] | 137 |
| Hoffmann la Roche (CH) | 130 |
| Amgen Inc [US] | 122 |
| Inst Nat Sante Rech Med [FR] | 122 |
| Univ Texas [US] | 118 |
| Centocor Inc [US] | 112 |
| Schering Corp [US] | 108 |
| Yeda Res & Dev [IL] | 100 |
| Pfizer Prod Inc [US] | 97 |
| Harvard College [US] | 91 |
| GlaxoSmithKline Biolog SA (BE) | 83 |
| Scripps Research Inst (US) | 78 |
| Dana Farber Cancer Inst Inc (US) | 77 |
| Gen Hospital Corp [US] | 77 |
| Merck & Co Inc (US) | 76 |
| Univ Michigan (US) | 74 |
| Biogen Idec Inc [US] | 73 |
| Astrazeneca AB [SE] | 72 |
| SmithKline Beecham Corp [US] | 71 |
| Pasteur Institut (FR) | 69 |
| Centre Nat Rech Scient (FR) | 68 |
| Zymogenetics Inc [US] | 65 |
| Univ Leland Stanford Junior [US] | 63 |
| Univ Florida (US) | 53 |